as 03-28-2025 4:00pm EST
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Founded: | 2005 | Country: | China |
Employees: | N/A | City: | N/A |
Market Cap: | 1.6M | IPO Year: | 2019 |
Target Price: | N/A | AVG Volume (30 days): | 1.6M |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -28.58 | EPS Growth: | N/A |
52 Week Low/High: | $2.40 - $26.96 | Next Earning Date: | 01-01-0001 |
Revenue: | $1,928,497 | Revenue Growth: | -2.19% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
SXTC Breaking Stock News: Dive into SXTC Ticker-Specific Updates for Smart Investing
MT Newswires
14 days ago
GlobeNewswire
14 days ago
GlobeNewswire
a month ago
GlobeNewswire
6 months ago
The Telegraph
10 months ago
Motley Fool
10 months ago
AFP
10 months ago
Simply Wall St.
10 months ago
The information presented on this page, "SXTC China SXT Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.